Carderock Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-22,823
Closed -$2.38M 80
2017
Q4
$2.38M Sell
22,823
-1,361
-6% -$154K 1.05% 45
2017
Q3
$3.53M Buy
24,184
+240
+1% +$32.7K 1.59% 31
2017
Q2
$3.11M Sell
23,944
-767
-3% -$94K 1.4% 34
2017
Q1
$3.08M Sell
24,711
-1,496
-6% -$179K 1.42% 35
2016
Q4
$3.03M Buy
26,207
+271
+1% +$30.2K 1.51% 33
2016
Q3
$2.71M Buy
25,936
+299
+1% +$32.4K 1.36% 37
2016
Q2
$2.53M Sell
25,637
-703
-3% -$72.7K 1.34% 35
2016
Q1
$2.64M Buy
26,340
+32
+0.1% +$3.29K 1.35% 32
2015
Q4
$3.15M Buy
26,308
+1,342
+5% +$155K 1.64% 27
2015
Q3
$2.7M Sell
24,966
-3,299
-12% -$409K 1.51% 29
2015
Q2
$3.27M Sell
28,265
-6,476
-19% -$740K 1.64% 26
2015
Q1
$4M Sell
34,741
-1,825
-5% -$218K 1.94% 23
2014
Q4
$4.09M Hold
36,566
2.01% 24
2014
Q3
$3.47M Buy
36,566
+346
+1% +$31.2K 1.78% 26
2014
Q2
$3.11M Sell
36,220
-662
-2% -$50.3K 1.62% 25
2014
Q1
$2.57M Sell
36,882
-472
-1% -$37.4K 1.31% 29
2013
Q4
$3.16M Sell
37,354
-3,480
-9% -$275K 1.65% 23
2013
Q3
$3.15M Sell
40,834
-4,964
-11% -$348K 1.82% 20
2013
Q2
$2.68M Buy
+45,798
New +$2.76M 1.58% 25

Other funds holding CELG

Carderock Capital Management's CELG Position: Q1 2018 in Review

Carderock Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 22,823 shares — an estimated $2.38M sold.

Carderock Capital Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $4.09M in Q4 2014. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Carderock Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Carderock Capital Management sold 22,823 Celgene Corp shares in Q1 2018, an estimated $2.38M.
  • Carderock Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Carderock Capital Management's Celgene Corp position peaked at $4.09M in Q4 2014.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Carderock Capital Management's 13F filing for Q1 2018, filed 27 Apr 2018.